Rchr
J-GLOBAL ID:201701017821046204   Update date: May. 06, 2021

Fujino Toshio

フジノ トシオ | Fujino Toshio
Affiliation and department:
Job title: 助教
Research field  (1): Tumor diagnostics and therapeutics
Research keywords  (4): EGFR ,  MET ,  Lung cancer ,  分子標的治療薬
Research theme for competitive and other funds  (3):
  • 2021 - 2023 肺癌の新規治療標的としてCBL遺伝子変異の解析
  • 2019 - 2021 Development of new treatment strategy for lung cancer haboring MET exon14 mutation
  • 2016 - 2019 Molecular targeted therapy against adenocarcinoma of the lung harboring MET exon 14 skipping mutation
Papers (22):
  • Masaya Nishino, Kenichi Suda, Takamasa Koga, Shuta Ohara, Toshio Fujino, Junichi Soh, Vijaya Tirunagaru, Avanish Vellanki, Robert C Doebele, Tetsuya Mitsudomi. Activity of tarloxotinib-E in cells with EGFR exon-20 insertion mutations and mechanisms of acquired resistance. Thoracic cancer. 2021
  • Kenichi Suda, Kazuko Sakai, Keiko Obata, Shuta Ohara, Toshio Fujino, Takamasa Koga, Akira Hamada, Junichi Soh, Kazuto Nishio, Tetsuya Mitsudomi. Inter- and Intratumor Heterogeneity of EGFR Compound Mutations in Non-Small Cell Lung Cancers: Analysis of Five Cases. Clinical lung cancer. 2021. 22. 2. e141-e145
  • Toshio Fujino, Tetsuya Mitsudomi. Acquired Resistance Mechanism for MET Tyrosine Kinase Inhibitor. JTO Clinical and Research Reports. 2021. 2. 3. 100134-100134
  • Toshiki Takemoto, Junichi Soh, Shuta Ohara, Toshio Fujino, Takamasa Koga, Masaya Nishino, Akira Hamada, Masato Chiba, Masaki Shimoji, Kenichi Suda, et al. The prevalence and risk factors associated with preoperative deep venous thrombosis in lung cancer surgery. Surgery today. 2021
  • Shuta Ohara, Kenichi Suda, Toshio Fujino, Akira Hamada, Takamasa Koga, Masaya Nishino, Masato Chiba, Masaki Shimoji, Toshiki Takemoto, Junichi Soh, et al. Dose-dependence in acquisition of drug tolerant phenotype and high RYK expression as a mechanism of osimertinib tolerance in lung cancer. Lung cancer (Amsterdam, Netherlands). 2021. 154. 84-91
more...
MISC (58):
Books (3):
  • Respiratory Journal
    2020
  • PROGRESS IN MEDCINE
    lifescience 2018 ISBN:9784898016374
  • 検診胸部X線写真の読影
    国際医学出版 2016 ISBN:4861022630
Lectures and oral presentations  (5):
  • Comprehensive analysis of secondary mutation as resistance mechanism to seven MET-TKIs for MET exon 14 skipping in vitro
    (2019)
  • In Vitro Evaluation for Optimal MET-TKI Selection in Lung Cancers with MET Mutations Including Exon 14 Skipping
    (19th World Conference on Lung Cancer 2018)
  • 外科的切除を行った胸膜播種,悪性胸水を伴う肺癌手術症例の検討
    (第 35回 日本呼吸器外科学会総会 2018)
  • 完全鏡視下左肺全摘と右開胸気管分岐部切除再建による左肺管状全摘
    (第 34回 日本呼吸器外科学会総会 2017)
  • 右肺上葉切除後のアスペルギルス症に対して、胸骨正中と後側方切開にて残存右肺全摘術を施 行した一例
    (第 33回 日本呼吸器外科学会総会 2016)
Education (2):
  • 2017 - 2020 Kindai University
  • 2006 - 2012 Nagoya City University
Awards (4):
  • 2020/11 - The Japan Lung Cancer Society Young Scientist Award
  • 2020/07 - 近畿大学 医学会賞
  • 2020/03 - Kindai University Kindai University President Award
  • 2017/02 - 静岡呼吸器外科医会 最優秀演題賞
Association Membership(s) (9):
IASLC ,  ASCO ,  THE JAPAN SOCIETY FOR RESPIRATORY ENDOSCOPY ,  THE JAPAN LUNG CANCER SOCIETY ,  THE JAPANESE ASSOCIATION FOR THORACIC SURGERY ,  The Japanese Association for Chest Surgery ,  JAPAN SURGICAL SOCIETY ,  THE JAPANESE CANCER ASSOCIATION ,  THE JAPANESE ASSOCIATION FOR MOLECULAR TARGET THERAPY OF CANCER
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page